05/15/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 5/15/2020. This 18-page report provides details about how several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children who were hospitalized in intensive care due to a rare pediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterized, among others, by fever, abdominal pain, and cardiac involvement. Risk communication is needed to raise awareness in the medical community about PIMS, and inform parents and caregivers about signs and symptoms. (PDF)
05/14/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 5/14/2020. This web page provides background information on several cases of a recently reported multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19); and a case definition for this syndrome. CDC recommends healthcare providers report any patient who meets the case definition to local, state, and territorial health departments to enhance knowledge of risk factors, pathogenesis, clinical course, and treatment of this syndrome. (Text)
05/14/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Energy and Commerce. Published: 5/14/2020. This six-hour, 21-minute Congressional hearing examines the federal response to the approaching COVID-19 pandemic, and federal efforts to develop and supply COVID-19 medical countermeasures. One witness discusses his whistleblower complaint about the federal response and the reasons for it, and another speaks to America's dependence on foreign countries for critical medical supplies. (Video or Multimedia)
05/13/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/13/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Linea™ COVID-19 Assay Kit, which received an Emergency Use Authorization from the Food and Drug Administration on May 13, 2020. The Linea™ COVID-19 Assay Kit is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
05/13/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/13/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of infusion pumps and infusion pump accessories. Certain infusion pumps and infusion pump accessories are authorized for emergency use by healthcare providers to treat conditions caused by the coronavirus disease 2019 (COVID-19) with the controlled infusion of medications, total parenteral nutrition (TPN), and/or other fluids. (PDF)
05/13/2020 12:00 AM EDT
Source: National Institute of Allergy and Infectious Diseases [National Institutes of Health] (NIAID). Published: 5/13/2020. This 58-minute presentation discusses issues related to designing and conducting treatment trials in outbreaks of Ebola and COVID-19 based on the speaker's experience with three studies: Prevail II (the West African Ebola virus disease study of ZMapp); PALM (the Democratic Republic of the Congo Ebola virus disease study of ZMapp, mAb114, REGN-EB3 and remdesivir); and ACTT-1 (the multinational, platform COVID-19 study of remdesivir vs. placebo). She discusses how a pandemic adds an overloaded medical system with limited resources for research, heightened pressure to find cures quickly, and unpredictability about potential case numbers. (Video or Multimedia)
05/13/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Oversight and Reform. Published: 5/13/2020. This one-hour, 15-minute recording is from the first briefing of the House Select Subcommittee on the Coronavirus Crisis, and features a bipartisan group of key experts on the requirements for safely reopening the nation during the coronavirus pandemic. Panelists have put forward plans to guide federal and state efforts to safely reopen the country, including the AEI Plan, the Hopkins Plan, the Harvard Plan, and the Duke-Margolis Center for Health Policy Plan. (Video or Multimedia)
05/11/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/11/2020. When there is a shortage of NIOSH-approved filtering facepiece respirators (FFRs), as we are experiencing during the coronavirus disease 2019 (COVID-19) pandemic, other reliable options must be found. This web page provides guidance about what to consider when purchasing respirators that meet the regulatory requirements of the countries listed in the FDA’s Emergency Use Authorization. It details key factors that should assist potential purchasers of international respirators in making informed procurement and distribution decisions to keep their workers safe. (Text)
05/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Europe. Published: 5/2020. The World Health Organization has developed some guidelines, materials, and apps on this web page that frontline healthcare providers may find useful when providing care for children with severe acute respiratory infections when COVID-19 is suspected. The WHO Pocket Book of Hospital Care for Children is available in several languages, including Armenian, Kazakh, Kyrgyz, Romanian, Russian, and Uzbek. Special attention is drawn to these sections, which are particularly relevant within the COVID-19 context: Chapter 4: information on cough and difficulty in breathing, pneumonia, and bronchiolitis; Chapter 10: information on essential supportive care including feeding, fluid and oxygen provision; and Annex 1: information on related practical procedures. (PDF)
05/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 5/1/2020. This one-hour webinar, held in English and Spanish, walks through what community health workers need to know about COVID-19 and their roles in the communities they serve during the emergency response efforts. Presenters discuss myths and rumors about COVID-19, cultural aspects for the prevention and treatment of the virus in the community, and CDC resources. The webinar was a collaboration with one of the CDC Emergency Partners Information Connection (EPIC) Partners, the National Association of Community Health Workers. (Video or Multimedia)
05/01/2020 12:00 AM EDT
Source: National Academy of Medicine (NAM). Published: 5/2020. This web page provides information and links to a webinar series from the National Academy of Medicine and the American Society of Addiction Medicine that provides insight and targeted guidance on how to ensure that individuals experiencing addiction are cared for and protected during the COVID-19 pandemic. (Video or Multimedia)
04/09/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Europe. Published: 4/9/2020. This five-page checklist is intended for use by policymakers and prison administrators to evaluate their level of preparedness to prevent and control COVID-19 in prisons and other places of detention. (PDF)
.png)
No hay comentarios:
Publicar un comentario